Articles

A panel of experts went over new regulatory requirements for contamination control and gave guidance on implementing a contamination control strategy in cell and gene therapy facilities at INTERPHEX 2024.

INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities 

Feliza Mirasol is the science editor for 

Videos

Mary Van Gaasbeck, technical services specialist, LS Equipment and Services, at STERIS Life Sciences, notes that automation is key when it comes to effective sterile powder transfer of parenteral drug products.

Taking a Deeper Look at Sterile Powder Transfer in Aseptic Fill/Finish of Parenterals (INTERPHEX 2024)

Andreas Frerix, product management director for Quattroflow at PSG Biotech, discussed the advantages and new challenges SUTs present for pumping systems.

Evaluating the Single-Use Trend in Pumping Systems for Fluid Handling (INTERPHEX 2024)

New regulations, including those put forth by Annex 1, require many pharmaceutical manufacturers to rethink their facility designs to promote compliance. 

How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design

Jay Rajagopalan, senior director—Engineering & Product Management for Malema at PSG Biotech, shared insights at on how current industry trends are shaping the development and advancement of sensor technologies.

A Look at the Impact of Industry Trends on Sensor Technologies (INTERPHEX 2024)

Pharmaceutical Technology® spoke with Nicole Hunter, Watson-Marlow Fluid Technology Solutions’ head of Global WMArchitect, about the impact single-use technologies have on fluid-handling workflows in bioprocessing.

Single-Use Technologies Reinforce Fluid-Handling Workflows (INTERPHEX 2024)

The improvement of ADC manufacturing now demands increased containment requirements and continually advancing analytical detection of molecules in manufacturing spaces.

Improving ADC Manufacture Means Stricter Containment Requirements and Continuous Advancement of Analytics (INTERPHEX 2024)

CordenPharma’s partnership with GENEPEP expedites lead development and validation in project phases, and its LNP β-sitosterol supports sustainable emission reduction targets.

CordenPharma Leverages Peptide Drug Discovery and Development with GENEPEP and Works on Reducing Emissions

Wenyu Zhang, PhD, addressed new trends in the aseptic industry and the chief concerns companies should keep in mind while weighing their options, at INTERPHEX 2024.

Disinfection of Manufacturing Environments: Balancing Efficacy and Cost of Cleaning with Safety and Environmental Impact (INTERPHEX 2024)

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Susan Schniepp, distinguished fellow, Regulatory Compliance Associates, and co-chair of board of directors, Parenteral Drug Association, demonstrates QMS impact on quality maturity at INTERPHEX.

News